SEC Form 4 · accession 0000899243-15-000435
Ocugen, Inc. · OCGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan I Lieber
Officer — Chief Financial Officer
Period of report
Jul 2, 2015
Accepted (ET)
Jul 6, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372299
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $6.39 | Jul 2, 2015 | A | 110,000 | A | — | Jul 2, 2025 | Common Stock | 110,000 | 110,000 | D |
| Employee Stock Option (Right to Buy)F2 | $6.39 | Jul 2, 2015 | A | 30,000 | A | — | Jul 2, 2025 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1This option vests over four (4) years of service following July 2, 2015, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service and the balance vesting in thirty-six (36) equal monthly installments thereafter.
- F2This option shall vest in full if the Issuer's Common Stock price reaches $19.92 per shares or above for any consecutive sixty (60) day period within four (4) years of the date of grant (the date such option vests, the "Vesting Date"). In addition, if this option is exercised within one (1) year of the Vesting Date, the Reporting Person must hold shares (net of taxes) until the one (1) year anniversary of the Vesting Date.
Remarks
See Remarks